Zymeworks Inc. ( ZYME) - Key Metrics
ZYME Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.03 | -$0.55 | -$0.13 | -$0.14 |
| 2025Q3 | $0.36 | -$0.26 | -$0.41 | -$0.42 |
| 2025Q2 | $0.65 | $0.03 | $0.16 | $0.15 |
| 2025Q1 | $0.36 | -$0.30 | -$0.05 | -$0.05 |
ZYME Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -12.03 |
| 2025Q3 | ? | -16.50 |
| 2025Q2 | ? | 102.02 |
| 2025Q1 | ? | -9.89 |
ZYME
Price: $25.08
52 week price:
Earnings Per Share: -1.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 105946
Ebitda: -15.5 millionMarket Capitalization: 1.8 billion